Healthcare corporate affairs and advocacy leader skilled in building meaningful alliances between multiple stakeholders including nongovernmental organizations, patient advocates, medical and scientific key opinion leaders, policymakers, and academia. US and global experience across the biopharmaceutical product lifecycle, from early-stage research to commercialization, pricing, access, and distribution. Deep experience in patient engagement, advocacy development, coalition-building, and disease awareness. Strong knowledge and understanding of multiple therapeutic areas including rare disease. Passionate about effecting change for people fighting serious disease, communicating complex science through storytelling, problem solving, and fostering patient-centric cross-functioning teams.
